Milestone Pharmaceuticals Inc. — All Filings
395 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEF 14A | 0001104659-23-053003 | Apr 28, 2023 | — |
| DEF 14A | DEF 14A | 0001104659-23-052993 | Apr 28, 2023 | Jun 7, 2023 |
| 8-K | FORM 8-K | 0001104659-23-039764 | Mar 31, 2023 | Mar 27, 2023 |
| 8-K | FORM 8-K | 0001104659-23-038073 | Mar 29, 2023 | — |
| 10-K | 10-K | 0001558370-23-004871 | Mar 29, 2023 | Dec 31, 2022 |
| 8-K | FORM 8-K | 0001104659-23-037370 | Mar 28, 2023 | Mar 27, 2023 |
| 8-K | FORM 8-K | 0001104659-23-037189 | Mar 27, 2023 | Mar 21, 2023 |
| 4 | — | 0000902664-23-002379 | Mar 24, 2023 | Mar 22, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-020844 | Mar 23, 2023 | Mar 21, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-020843 | Mar 23, 2023 | Mar 21, 2023 |
| 8-K | FORM 8-K | 0001104659-23-031319 | Mar 10, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-029345 | Mar 7, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010703 | Feb 17, 2023 | Feb 16, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010700 | Feb 17, 2023 | Feb 16, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010697 | Feb 17, 2023 | Feb 16, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010707 | Feb 17, 2023 | Feb 16, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010705 | Feb 17, 2023 | Feb 16, 2023 |
| SC 13G/A | SC 13G/A | 0001104659-23-021606 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000895345-23-000140 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-037890 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021796 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000947871-23-000181 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001306550-23-008628 | Feb 13, 2023 | — |
| SC 13G/A | — | 0001319244-23-000006 | Jan 18, 2023 | — |
| 8-K | FORM 8-K | 0001104659-22-124907 | Dec 6, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-059720 | Dec 5, 2022 | Dec 1, 2022 |
| 10-Q | 10-Q | 0001558370-22-017283 | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | FORM 8-K | 0001104659-22-117099 | Nov 10, 2022 | — |
| SC 13G | — | 0001319244-22-000176 | Oct 31, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-267365 | Oct 24, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-054326 | Oct 21, 2022 | Oct 20, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-054325 | Oct 21, 2022 | Oct 19, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-054328 | Oct 21, 2022 | Oct 19, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-054327 | Oct 21, 2022 | Oct 20, 2022 |
| 8-K | FORM 8-K | 0001104659-22-108996 | Oct 17, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-251250 | Sep 26, 2022 | — |
| SC 13G | SC 13G | 0001104659-22-101288 | Sep 20, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-050075 | Sep 15, 2022 | Sep 14, 2022 |
| 4 | — | 0000902664-22-004219 | Sep 9, 2022 | Sep 7, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-046505 | Aug 17, 2022 | Aug 9, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-045472 | Aug 11, 2022 | Jul 5, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-045471 | Aug 11, 2022 | Jul 5, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-045468 | Aug 11, 2022 | Jul 5, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-045474 | Aug 11, 2022 | Jul 5, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-045475 | Aug 11, 2022 | Jul 5, 2022 |
| 8-K | FORM 8-K | 0001104659-22-088661 | Aug 10, 2022 | — |
| 10-Q | 10-Q | 0001558370-22-013074 | Aug 10, 2022 | Jun 30, 2022 |
| 8-K | FORM 8-K | 0001104659-22-078354 | Jul 8, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033336 | Jun 1, 2022 | May 31, 2022 |
| 10-Q | 10-Q | 0001558370-22-008418 | May 12, 2022 | Mar 31, 2022 |